Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | S26 - Experimental Therapeutics in Dementia

Tuesday 04/25/23
01:00 PM - 03:00 PM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Scientific Platform Session
Aging, Dementia, Cognitive, and Behavioral Neurology
A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes for question and answer with the author.
2.00 CME credits
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Didactic

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:24 PM EST Speaker 2023 Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases: This award recognizes major contributions to the understanding of the causes, prevention, treatment, and cure for Pick's, Alzheimer's, and related diseases.
Maria Luisa Gorno Tempini, MD, PhD
01:36 PM - 01:48 PM EST Abstract 004 - Rational design of a vaccine for Alzheimer’s disease using computationally-derived conformational B cell epitopes to selectively target toxic amyloid-beta oligomers
Johanne M. Kaplan, PhD
01:48 PM - 02:00 PM EST Abstract 005 - Using Predictive Models to Reduce Heterogeneity in Alzheimer’s Disease Clinical Trials
Ali Ezzati, MD
02:00 PM - 02:12 PM EST Abstract 006 - ALUMNI AD Study Design: Evaluation of Subcutaneous Gantenerumab in Historically Underrepresented US Populations With Early Symptomatic Alzheimer’s Disease
Sheila Seleri
02:12 PM - 02:24 PM EST Abstract 007 - Effects of ALZ-801, an Oral Amyloid Oligomer Inhibitor, on Biomarkers of Alzheimer’s Disease (AD): 12-Month Results of Phase 2 Biomarker Study in Early AD
John A. Hey, PhD
02:24 PM - 02:36 PM EST Abstract 008 - Fosgonimeton Provides Congruent Improvements on Neurodegeneration Biomarkers, Significantly Correlating With Composite Clinical Score of Cognition and Function in Alzheimer’s Disease
Hans J. Moebius, MD, PhD, FAAN
02:36 PM - 02:48 PM EST Abstract 009 - TRAILBLAZER-ALZ 4: Topline study results directly comparing donanemab to aducanumab on amyloid lowering in early, symptomatic Alzheimer’s disease
Stephen P. Salloway, MD, MS
02:48 PM - 03:00 PM EST Abstract 010 - GRADUATE I AND II: Findings of Two Phase III Randomized Placebo-controlled Studies Assessing the Efficacy and Safety of Subcutaneous Gantenerumab in Early Alzheimer’s Disease (AD)
Janice W. Smith, PhD
Faculty Disclosures
Marco Lyons Marco Lyons has nothing to disclose.
Sharon A. Brangman, MD Dr. Brangman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Brangman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech-Roche. Dr. Brangman has received personal compensation in the range of $0-$499 for serving as a Consultant for Acadia. Dr. Brangman has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai. Dr. Brangman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Brangman has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Columbian Financial Group. Dr. Brangman has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various Legal Firms. The institution of Dr. Brangman has received research support from National Institute on Aging. The institution of Dr. Brangman has received research support from NYS Health Foundation. The institution of Dr. Brangman has received research support from American Geriatrics Society.
Michael C. Donohue, PhD An immediate family member of Prof. Donohue has received personal compensation for serving as an employee of Janssen. Prof. Donohue has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Prof. Donohue has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. An immediate family member of Prof. Donohue has stock in Janssen. The institution of Prof. Donohue has received research support from NIH.
Charles Bernick, MD Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Optina. Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corium. Dr. Bernick has stock in Aurora. The institution of Dr. Bernick has received research support from UFC. The institution of Dr. Bernick has received research support from Top Rank Promotions. The institution of Dr. Bernick has received research support from Haymon Boxing.
Helen C. Lin, MD Dr. Lin has received personal compensation for serving as an employee of Genentech. Dr. Lin has stock in Genentech.
Emer McGrath, MBChB Dr. McGrath has nothing to disclose.
Ming Lu Ming Lu has received personal compensation for serving as an employee of Eli Lilly and Company. Ming Lu has received stock or an ownership interest from Eli Lilly and Company.
Niels D. Prins, MD Dr. Prins has stock in Brain Research Center. Dr. Prins has received personal compensation in the range of $100,000-$499,999 for serving as a CEO with Brain Research Center.
Claudia L. Satizabal, PhD The institution of Dr. Satizabal has received research support from NIH and TARCC.
Richard J. Perry, MD Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Perry has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. Perry has received personal compensation in the range of $0-$499 for serving as a Consultant for Eli Lilly. Dr. Perry has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Emily Catherine Collins, PhD Dr. Collins has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Collins has stock in Eli Lilly and Company.
Stephen P. Salloway, MD, MS Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EISAI. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lilly. Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NovoNordisk. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Prothena. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bolden. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly.
Michael G. Case, MS Mr. Case has received personal compensation for serving as an employee of Eli Lilly and Company. Mr. Case has received stock or an ownership interest from Eli Lilly and Company.
Alexa Beiser Alexa Beiser has received research support from NIH.
Elisabeth Gruendl, PhD Dr. Gruendl has received personal compensation for serving as an employee of F. Hoffmann-La Roche AG. Dr. Gruendl has stock in F. Hoffmann-La Roche AG.
Kaj Blennow Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Axon, JOMDD, Roche, Siemens. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, Julius Clinical. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MagQu.
Aidan Power, PhD Dr. Power has received personal compensation for serving as an employee of Alzheon. Dr. Power has stock in Pfizer. Dr. Power has stock in Alzheon.
Johanne M. Kaplan, PhD Dr. Kaplan has received personal compensation for serving as an employee of ProMIS Neurosciences. Dr. Kaplan has stock in ProMIS Neurosciences. Dr. Kaplan has received intellectual property interests from a discovery or technology relating to health care.
Sandra E. Black, MD, FAAN Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Black has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Black has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Limited . Dr. Black has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Black has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Black has received research support from Hoffmann-La Roche. The institution of Dr. Black has received research support from Biogen. The institution of Dr. Black has received research support from GE Healthcare. The institution of Dr. Black has received research support from Eli Lilly. The institution of Dr. Black has received research support from Genentech. The institution of Dr. Black has received research support from NovoNordisk. The institution of Dr. Black has received research support from UCB Biopharma. The institution of Dr. Black has received research support from Alkahest Inc. The institution of Dr. Black has received research support from University of Southern California - AHEAD 3-45 Study.
Bhargav Nallapu Bhargav Nallapu has nothing to disclose.
Tobias Bittner Tobias Bittner has received personal compensation for serving as an employee of F.Hoffmann-LaRoche. Tobias Bittner has stock in F.Hoffmann-LaRoche.
Margaret Ferguson Margaret Ferguson has received personal compensation for serving as an employee of Eli Lilly. Margaret Ferguson has stock in Eli Lilly.
Timo Grimmer, MD Dr. Grimmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie, Alector, Anavex, Biogen, Eli Lilly, Functional Neuromodulation, Grifols, Iqvia, Noselab, Novo Nordisk, NuiCare, Orphanzyme, Roche Diagnostics, Roche Pharma, UCB, and Vivoryon. Dr. Grimmer has received personal compensation in the range of $500-$4,999 for serving as a lecturer with Grifols, Medical Tribune, Novo Nordisk, Roche Pharma, and Schwabe.
Rosalind Mandelbaum, PA No disclosure on file
Ali Ezzati, MD Dr. Ezzati has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mist Research. Dr. Ezzati has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BioDelivery Sciences International (BDSI) . The institution of Dr. Ezzati has received research support from NIA. The institution of Dr. Ezzati has received research support from Alzheimer's Association. The institution of Dr. Ezzati has received research support from Cure Alzheimer's Fund.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has stock in Biohaven. Dr. Lipton has stock in Manistee. Dr. Lipton has stock in Axon. Dr. Lipton has stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Alexandria Wise-Brown, PhD Dr. Wise-Brown has received personal compensation for serving as an employee of Genentech.
Scott Napper, PhD The institution of Dr. Napper has received research support from Weston Family Foundation.
Dawn A. Brooks, PhD An immediate family member of Dr. Brooks has received personal compensation for serving as an employee of Indiana Hospital Association. Dr. Brooks has received stock or an ownership interest from Eli Lilly and Company.
Paulo Pacheco Fontoura, MD, PhD, FAAN Dr. Fontoura has received personal compensation for serving as an employee of F. Hoffmann La Roche. Dr. Fontoura has stock in Roche Pharmaceuticals.
Juliane Ashleigh Coutts, Other Ms. Coutts has nothing to disclose.
Ruiqi Wang, Other Mr. Wang has nothing to disclose.
Sharay E. Setti, PhD Dr. Setti has received personal compensation for serving as an employee of Athira Pharma. Dr. Setti has stock in Athira Pharma.
Janice W. Smith, PhD Dr. Smith has received personal compensation for serving as an employee of Roche Products Ltd. Dr. Smith has stock in Hoffman La Roche.
Andrew John Kinsman Pain, MBBS Dr. Pain has received personal compensation for serving as an employee of Eli Lilly & Co. Dr. Pain has stock in Eli Lilly.
Sheila Seleri Sheila Seleri has received personal compensation for serving as an employee of Genentech, a member of the Roche group. Sheila Seleri has stock in Genentech, a member of the Roche group.
Elly Lee No disclosure on file
Matteo Tonietto Matteo Tonietto has received personal compensation for serving as an employee of Roche. Matteo Tonietto has stock in Roche.
Jacobo E. Mintzer Jacobo E. Mintzer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AARP - Global Council on Brain Health. Jacobo E. Mintzer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AARP - "Staying Sharp" Scientific Advisory Board. Jacobo E. Mintzer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ACADIA. Jacobo E. Mintzer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech (affiliate of F. Hoffmann-La Roche Ltd). Jacobo E. Mintzer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health and Wellness Partners, LLC. Jacobo E. Mintzer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ironshore Pharmaceuticals. Jacobo E. Mintzer has received personal compensation in the range of $0-$499 for serving as a Consultant for Praxis Bioresearch. Jacobo E. Mintzer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sygnature Discovery. Jacobo E. Mintzer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AARP - "Staying Sharp" Scientific Advisory Board. Jacobo E. Mintzer has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Study Title: NAB-It: Nabilone for Agitation Blinded Intervention Trial. Jacobo E. Mintzer has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Study Title: WeCareAdvisory Study. Jacobo E. Mintzer has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Technology Accelerator Company (TAC). Jacobo E. Mintzer has stock in Biopharma Connex. Jacobo E. Mintzer has stock in NeuroQuest. Jacobo E. Mintzer has stock in Recruitment Partners. The institution of Jacobo E. Mintzer has received research support from Eisai Inc.. The institution of Jacobo E. Mintzer has received research support from Alzheimer's Clinical Trials Consortium. The institution of Jacobo E. Mintzer has received research support from Eli Lilly and Company. The institution of Jacobo E. Mintzer has received research support from Alzheimer's Therapeutic Research Institute. The institution of Jacobo E. Mintzer has received research support from JHSPH Center for Clinical Trials. Jacobo E. Mintzer has received personal compensation in the range of $0-$499 for serving as a Steering Committee Member with Alzheimer's Clinical Trials Consortium (ACTC). Jacobo E. Mintzer has received personal compensation in the range of $0-$499 for serving as a Steering Committee Member with Alzheimer's Disease Cooperative Study (ADCS). Jacobo E. Mintzer has received personal compensation in the range of $0-$499 for serving as a Steering Committee Member with Elder Court. Jacobo E. Mintzer has received personal compensation in the range of $0-$499 for serving as a Unpaid Consultant/Association Member with International Psychogeriatric Association (IPA).
Saptaparni Ghosh Saptaparni Ghosh has nothing to disclose.
Monica Lauren Parker, MD Dr. Parker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Parker has received research support from NIH. Dr. Parker has received personal compensation in the range of $500-$4,999 for serving as a Patient Engagement Advisory Committee with FDA.
Loes Rutten-Jacobs, PhD Dr. Rutten-Jacobs has received personal compensation for serving as an employee of F.Hoffmann-La Roche Ltd.. Dr. Rutten-Jacobs has stock in F.Hoffmann-La Roche Ltd..
Michael Grundman, MD, MPH Dr. Grundman has received personal compensation for serving as an employee of Global R&D Partners.
Martin David Mulligan, MD Dr. Mulligan has nothing to disclose.
Michael Don Hale, PhD Dr. Hale has received personal compensation for serving as an employee of Athira Pharma. Dr. Hale has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Takeda. Dr. Hale has stock in Amgen.
Frederik Barkhof, MD, PhD Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Frederik Barkhof has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Combinostics. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IXICO. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI.
Hong Wang, PhD Mrs. Wang has received personal compensation for serving as an employee of Eli Lilly and company.
Neil R. Cashman, MD Dr. Cashman has received personal compensation for serving as an employee of ProMIS Neurosciences. Dr. Cashman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi-Tanabe. Dr. Cashman has stock in ProMIS Neurosciences. The institution of Dr. Cashman has received research support from ProMIS Neurosciences. Dr. Cashman has received intellectual property interests from a discovery or technology relating to health care. Dr. Cashman has a non-compensated relationship as a BoD memeber with ALS Society of BC that is relevant to AAN interests or activities.
Ladislav Pazdera, MD, FAAN Dr. Pazdera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Pazdera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Chris Pelentrides, Other Mr. Pelentrides has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Ebrima Gibbs, Bsc,BMLSc,MSc Dr. Gibbs has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Promis Neuroscinces.
Monika Baudler Monika Baudler has received personal compensation for serving as an employee of Roche. Monika Baudler has stock in Roche.
Martin Tolar, MD, PhD Dr. Tolar has received personal compensation for serving as an employee of Alzheon. Dr. Tolar has received intellectual property interests from a discovery or technology relating to health care.
Sterre Malou Rutgers, MD Mrs. Rutgers has received personal compensation for serving as an employee of Brain Research Center Amsterdam B.V..
Sudha Seshadri, MD, FAAN Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Seshadri has received research support from NIH. The institution of Dr. Seshadri has received research support from Alzheimer Association.
Gregory A. Rippon, MD, FAAN Dr. Rippon has received personal compensation for serving as an employee of Genentech. Dr. Rippon has stock in Genentech.
Katerina Sheardova, MD,PhD Dr. Sheardova has stock in Alzheon.
Philip Scheltens, MD, PhD, FAAN Dr. Scheltens has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVO NOrdisk.
Kellen Petersen KELLEN Petersen has nothing to disclose.
Joseph Neil Henderson, PhD Dr. Henderson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Henderson has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for International Association for Indigenous Aging. Dr. Henderson has received publishing royalties from a publication relating to health care.
Kayla Nicole Kleist Mrs. Kleist has received personal compensation for serving as an employee of Athira Pharma. Mrs. Kleist has received personal compensation for serving as an employee of Alpine Immune Sciences. Mrs. Kleist has stock in Athira Pharma. Mrs. Kleist has stock in Alpine Immune Sciences.
Kai-Bin Ceres Ooi, Other Ms. Ooi has received personal compensation for serving as an employee of Athira Pharma Inc. Ms. Ooi has stock in Athira Pharma Inc.
Michelle Papka, PhD The institution of Dr. Papka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. The institution of Dr. Papka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Papka has received personal compensation in the range of $1,000,000+ for serving as a Owner: Clinical Trials Practice with multiple.
Ena Oru, MD Dr. Oru has received personal compensation for serving as an employee of Eli Lilly.
Paul L. Dautzenberg, PhD Dr. Dautzenberg has nothing to disclose.
Russell Tracy The institution of Russell Tracy has received research support from Nih.
Jakub Hort, MD Dr. Hort has received personal compensation in the range of $0-$499 for serving as a Consultant for Alzheimerchain. Dr. Hort has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Hort has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Schwabe. Dr. Hort has stock in Alzheon.
Qiong Yang, PhD Dr. Yang has nothing to disclose.
Beverly Assman Beverly Assman has nothing to disclose.
Patrick Kesslak No disclosure on file
Stephanie Monroe, Other Ms. Monroe has received personal compensation for serving as an employee of UsAgainstAlzheimer's. Ms. Monroe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with University of Southern California.
Rachelle S. Doody, MD, PhD Dr. Doody has received personal compensation for serving as an employee of F. Hoffman-LaRoche. Dr. Doody has stock in F. Hoffman-LaRoche.
John R. Sims, MD Dr. Sims has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Sims has stock in Eli Lilly and Company.
John A. Hey, PhD Dr. Hey has received personal compensation for serving as an employee of Alzheon. Dr. Hey has stock in Alzheon. Dr. Hey has stock in Alzheon. Dr. Hey has received intellectual property interests from a discovery or technology relating to health care.
Sawsan (Susan) R. Abushakra, MD Dr. Abushakra has received personal compensation for serving as an employee of Alzheon Inc. Dr. Abushakra has stock in Alzheon Inc. The institution of Dr. Abushakra has received research support from NIA. Dr. Abushakra has received intellectual property interests from a discovery or technology relating to health care.
Erin Scruten, Other Ms. Scruten has nothing to disclose.
Hans J. Moebius, MD, PhD, FAAN Dr. Moebius has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Athira Pharma, Inc.. Dr. Moebius has stock in Athira Pharma, Inc..
Maria Luisa Gorno Tempini, MD, PhD The institution of Dr. Gorno Tempini has received research support from NIH.
Sharon Sha, MD Dr. Sha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Sha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ExpertConnect. Dr. Sha has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Sha has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Forefront Collaborative. Dr. Sha has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ReachMD. The institution of Dr. Sha has received research support from Biogen. The institution of Dr. Sha has received research support from Jannssen. The institution of Dr. Sha has received research support from UCB Pharma. The institution of Dr. Sha has received research support from Genentech. The institution of Dr. Sha has received research support from Eisai. The institution of Dr. Sha has received research support from Eli Lilly. Dr. Sha has received publishing royalties from a publication relating to health care.
Julio C. Rojas-Martinez, MD, PhD The institution of Dr. Rojas-Martinez has received research support from NIH/NIA. The institution of Dr. Rojas-Martinez has received research support from Eli Lilly. The institution of Dr. Rojas-Martinez has received research support from Eisai.